Skip to content

Clinical study of Buerger exercise combined with vitamin D in the treatment of diabetic foot

Clinical study of Buerger exercise combined with vitamin D in the treatment of diabetic foot

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043815
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot

Interventions

Routine group:Routine dressing and debridement
Buerger exercise group:Routine treatment combined with Buerger movement
Vitamin D group:Conventional treatment combined with vitamin D
Joint group:Routine treatment combined with Buerger exercise knot vitamin D synthesis

Sponsors

General Hospital of TISCO
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria included: 1. According to the diagnostic criteria of the American Diabetes Association (ADA) in 1997, all patients were diagnosed as DFU. 2. According to Wagner classification, diabetic patients with grade I - III are classified.

Exclusion criteria

Exclusion criteria: The exclusion criteria included: 1. Patients with acute complications of diabetes; 2. Patients with cardiac insufficiency above grade 3 were accompanied by acute myocardial infarction, severe arrhythmia and acute stroke; 3. Patients with end-stage renal disease, severe infection, severe liver disease, etc.; 4. Patients with joint degeneration and other muscle and joint diseases which affect the activity function; 5. Patients who can't cooperate with relevant treatment measures and can't carry out exercise training on their own; 6. Amputated patients; 7. Patients who quit actively in the process of intervention; 8. Patients who can not complete the exercise according to the intervention requirements; 9. Patients who refused to participate in the measurement of observation indexes after intervention.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;TNF-a;Insulin resistance index;

Secondary

MeasureTime frame
VAS pain score;SF-36 quality of life scale;body mass index,BMI;

Countries

China

Contacts

Public ContactZhang Wei

General Hospital of TISCO

mrzhangczyx@163.com+86 18834842984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026